Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

David R. Spigel; Corinne Faivre-Finn; Jhanelle E. Gray; David Vicente; David Planchard; Luis Paz-Ares; Johan F. Vansteenkiste; Marina C. Garassino; Rina Hui; Xavier Quantin

doi:10.1200/jco.21.01308

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Identifier:nobleid.org/w1/20260526/DFBC20F5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFBC20F5.svg?ark=w1%2F20260526%2FDFBC20F5)](https://nobleid.org/work/w1/20260526/DFBC20F5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Johan F. Vansteenkiste

Marina C. Garassino

Rina Hui

Xavier Quantin

Claim authorship of this work

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Identifier:nobleid.org/w1/20260526/DFBC20F5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFBC20F5.svg?ark=w1%2F20260526%2FDFBC20F5)](https://nobleid.org/work/w1/20260526/DFBC20F5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Johan F. Vansteenkiste

Marina C. Garassino

Rina Hui

Xavier Quantin

Claim authorship of this work